The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Pain-related conditions cost the U.S. economy a staggering $635 billion annually in medical expenses and lost productivity.

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...

A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

With Trump's tariffs looming, is this really the appropriate time to load up on pharma stocks? And where does Cipla stand in ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer ...